BioMarin Announces EMA Grants Accelerated Assessment for Cerliponase Alfa, Experimental Treatment for a Form of Batten Disease
BioMarin Receives European Orphan Drug Designation for BMN 270, First Investigational AAV-Factor VIII Gene Therapy for Patients with Hemophilia A
Sranan Gold Initiates Diamond Core Drilling Program on the Randy Trend at the Tapanahony Project in Suriname
Silver47 Unveils Multiple Premier Exploration Targets with Strong Discovery Potential Across the Red Mountain Project, Alaska
